Sirona Biochem Valuation
| SBM Stock | CAD 0.08 0.01 6.67% |
Sirona Biochem seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of Sirona Biochem Corp from inspecting the company fundamentals such as Return On Equity of -98.1, current valuation of 23.99 M, and Shares Owned By Insiders of 10.56 % as well as reviewing its technical indicators and probability of bankruptcy.
Price Book 41.6366 | Enterprise Value 24 M | Enterprise Value Ebitda (7.92) | Price Sales 456.2159 | Enterprise Value Revenue 447.502 |
Overvalued
Today
Please note that Sirona Biochem's price fluctuation is out of control at this time. Calculation of the real value of Sirona Biochem Corp is based on 3 months time horizon. Increasing Sirona Biochem's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Sirona stock is determined by what a typical buyer is willing to pay for full or partial control of Sirona Biochem Corp. Since Sirona Biochem is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Sirona Stock. However, Sirona Biochem's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.08 | Real 0.0674 | Hype 0.07 | Naive 0.0846 |
The intrinsic value of Sirona Biochem's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Sirona Biochem's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Sirona Biochem Corp helps investors to forecast how Sirona stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Sirona Biochem more accurately as focusing exclusively on Sirona Biochem's fundamentals will not take into account other important factors: Sirona Biochem Cash |
|
Sirona Biochem Total Value Analysis
Sirona Biochem Corp is at this time estimated to have takeover price of 23.99 M with market capitalization of 20.71 M, debt of 637.65 K, and cash on hands of 376.43 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Sirona Biochem fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
23.99 M | 20.71 M | 637.65 K | 376.43 K |
Sirona Biochem Investor Information
The company recorded a loss per share of 0.01. Sirona Biochem Corp last dividend was issued on the 27th of December 2006. Based on the analysis of Sirona Biochem's profitability, liquidity, and operating efficiency, Sirona Biochem Corp is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December.Sirona Biochem Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Sirona Biochem has an asset utilization ratio of 3.37 percent. This indicates that the Company is making C$0.0337 for each dollar of assets. An increasing asset utilization means that Sirona Biochem Corp is more efficient with each dollar of assets it utilizes for everyday operations.Sirona Biochem Ownership Allocation
Sirona Biochem Corp shows a total of 258.84 Million outstanding shares. Sirona Biochem Corp has 10.56 % of its outstanding shares held by insiders and 0.0 % owned by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Sirona Biochem Profitability Analysis
The company reported the revenue of 34.78 K. Net Loss for the year was (2.54 M) with profit before overhead, payroll, taxes, and interest of 621.75 K.About Sirona Biochem Valuation
Our relative valuation model uses a comparative analysis of Sirona Biochem. We calculate exposure to Sirona Biochem's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Sirona Biochem's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 156.1 K | 220.5 K |
Additional Tools for Sirona Stock Analysis
When running Sirona Biochem's price analysis, check to measure Sirona Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sirona Biochem is operating at the current time. Most of Sirona Biochem's value examination focuses on studying past and present price action to predict the probability of Sirona Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sirona Biochem's price. Additionally, you may evaluate how the addition of Sirona Biochem to your portfolios can decrease your overall portfolio volatility.